Why sex matters: the biological mechanisms of cardiovascular disease

References

• Stramba-Badiale M, European Heart Health Strategy. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project. Eur Heart J 2010;31:1677–1681.
   Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the american heart association. Circulation 2011;123:1243–1262.
   PubMed Web of Science ®Google Scholar
• Bugiardini R, Yan AT, Yan RT, Fitchett D, Langer A, Manfrini O, Goodman SG; Canadian Acute Coronary Syndrome Registry I and II Investigators. Factors influencing underutilization of evidence-based therapies in women. Eur Heart J 2011;32:1337–1344.
   PubMed Web of Science ®Google Scholar
• Johnston N, Schenck-Gustafsson K, Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur Heart J 2011;32:1331–1336.
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–1811.
   PubMed Web of Science ®Google Scholar
• Villablanca AC, Jayachandran M, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci 2010;119:493–513.
   PubMed Web of Science ®Google Scholar
• Simoncini T. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric 2009;12 Suppl 1:6–11.
   PubMedGoogle Scholar
• Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 1993;14:459–479.
   PubMed Web of Science ®Google Scholar
• Fu XD, Simoncini T. Extra-nuclear signaling of estrogen receptors. IUBMB Life 2008;60:502–510.
   PubMed Web of Science ®Google Scholar
• Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199–1208.
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847–3853.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Gilbert JJ, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 2009;92:1171–1186.
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Gender differences in cardiovascular disease: hormonal and biochemical influences. Reprod Sci 2010;17:511–531.
   PubMed Web of Science ®Google Scholar
• Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F, Gourdy P. Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 2010;30:1506–1512.
   PubMed Web of Science ®Google Scholar
• Favre J, Gao J, Henry JP, Remy-Jouet I, Fourquaux I, Billon-Gales A, Thuillez C, et al. Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion. Arterioscler Thromb Vasc Biol 2010;30:2562–2567.
   PubMed Web of Science ®Google Scholar
• Broughton BR, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol 2010;298:H1055–H1061.
   PubMed Web of Science ®Google Scholar
• Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res 2002;53:597–604.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538–541.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Garibaldi S, Fu XD, Pisaneschi S, Begliuomini S, Baldacci C, Lenzi E, et al. Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause 2008;15:542–550.
   PubMed Web of Science ®Google Scholar
• Strehlow K, Rotter S, Wassmann S, Adam O, Grohé C, Laufs K, Böhm M, Nickenig G. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003;93:170–177.
   PubMed Web of Science ®Google Scholar
• Behl C, Skutella T, Lezoualc’h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997;51:535–541.
   PubMed Web of Science ®Google Scholar
• Miller AA, De Silva TM, Jackman KA, Sobey CG. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 2007;34:1037–1043.
   PubMed Web of Science ®Google Scholar
• Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 2002;22:438–442.
   PubMed Web of Science ®Google Scholar
• Vassalle C, Maffei S, Boni C, Zucchelli GC. Gender-related differences in oxidative stress levels among elderly patients with coronary artery disease. Fertil Steril 2008;89:608–613.
   PubMed Web of Science ®Google Scholar
• Vassalle C, Novembrino C, Maffei S, Sciarrino R, De Giuseppe R, Vigna L, de Liso F, et al. Determinants of oxidative stress related to gender: relevance of age and smoking habit. Clin Chem Lab Med 2011;49:1509–1513.
   PubMed Web of Science ®Google Scholar
• Gross M, Steffes M, Jacobs DR Jr, Yu X, Lewis L, Lewis CE, Loria CM. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem 2005;51:125–131.
   PubMed Web of Science ®Google Scholar
• Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metab Clin Exp 2008;57:961–965.
   PubMed Web of Science ®Google Scholar
• Goglia L, Tosi V, Sanchez AM, Flamini MI, Fu XD, Zullino S, Genazzani AR, Simoncini T. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol Hum Reprod 2010;16:761–769.
   PubMed Web of Science ®Google Scholar
• Mukherjee TK, Dinh H, Chaudhuri G, Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci USA 2002;99:4055–4060.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, Varone G, Caruso A, Genazzani AR. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 2003;144:3449–3455.
   PubMed Web of Science ®Google Scholar
• Arnal JF, Gourdy P, Simoncini T. Interference of progestins with endothelial actions of estrogens: a matter of glucocorticoid action or deprivation? Arterioscler Thromb Vasc Biol 2009;29:441–443.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Mannella P, Fornari L, Caruso A, Willis MY, Garibaldi S, Baldacci C, Genazzani AR. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004;145:5745–5756.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Genazzani AR. A review of the cardiovascular and breast actions of drospirenone in preclinical studies. Climacteric 2010;13:22–33.
   PubMed Web of Science ®Google Scholar
• Simoncini T, Fu XD, Caruso A, Garibaldi S, Baldacci C, Giretti MS, Mannella P, et al. Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. Hum Reprod 2007;22:2325–2334.
   PubMed Web of Science ®Google Scholar
• Ma Y, Qiao X, Falone AE, Reslan OM, Sheppard SJ, Khalil RA. Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat. Cell Physiol Biochem 2010;26:457–470.
   PubMedGoogle Scholar
• Kawagoe J, Ohmichi M, Tsutsumi S, Ohta T, Takahashi K, Kurachi H. Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells. Endocrinology 2007;148:6092–6099.
   PubMed Web of Science ®Google Scholar
• Zhu C, Zhang L, Zheng Y, Xu J, Song J, Rolfe BE, Campbell JH. Effects of estrogen on stress-induced premature senescence of vascular smooth muscle cells: a novel mechanism for the “time window theory” of menopausal hormone therapy. Atherosclerosis 2011;215:294–300.
   PubMed Web of Science ®Google Scholar
• Wassmann K, Wassmann S, Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 2005;97:1046–1054.
   PubMed Web of Science ®Google Scholar
• Cutini PH, Massheimer VL. Role of progesterone on the regulation of vascular muscle cells proliferation, migration and apoptosis. Steroids 2010;75:355–361.
   PubMed Web of Science ®Google Scholar
• Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995;91:1154–1160.
   PubMed Web of Science ®Google Scholar
• Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 1996;94:2614–2619.
   PubMed Web of Science ®Google Scholar
• Merz CN, Moriel M, Rozanski A, Klein J, Berman DS. Gender-related differences in exercise ventricular function among healthy subjects and patients. Am Heart J 1996;131:704–709.
   PubMed Web of Science ®Google Scholar
• Stefanelli CB, Rosenthal A, Borisov AB, Ensing GJ, Russell MW. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity. Mol Genet Metab 2004;83:188–196.
   PubMed Web of Science ®Google Scholar
• Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009;54:919–927.
   PubMed Web of Science ®Google Scholar
• Iellamo F, Volterrani M, Caminiti G, Karam R, Massaro R, Fini M, Collins P, Rosano GM. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 2010;56:1310–1316.
   PubMed Web of Science ®Google Scholar
• Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med 2002;40:371–377.
   PubMed Web of Science ®Google Scholar
• Clerico A, Fontana M, Vittorini S, Emdin M. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clin Chim Acta 2009;405:1–7.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006;5:425–438.
   PubMed Web of Science ®Google Scholar
• González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol Lett 2010;133:6–13.
   PubMed Web of Science ®Google Scholar
• Huang A, Kaley G. Gender-specific regulation of cardiovascular function: estrogen as key player. Microcirculation 2004;11:9–38.
   PubMed Web of Science ®Google Scholar
• Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002;160:91–102.
   PubMed Web of Science ®Google Scholar
• Fraser A, May M, Lowe G, Rumley A, Smith GD, Ebrahim S, Lawlor DA. Interleukin-6 and incident coronary heart disease: results from the British Women’s Heart and Health Study. Atherosclerosis 2009;202:567–572.
   PubMed Web of Science ®Google Scholar
• Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008;5:e78.
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285–1295.
   PubMed Web of Science ®Google Scholar
• Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011;31:27–33.
   PubMed Web of Science ®Google Scholar
• Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008;173:1210–1219.
   PubMed Web of Science ®Google Scholar
• Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009;335:143–151.
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Litwiller RD, Owen WG, Heit JA, Behrenbeck T, Mulvagh SL, Araoz PA, et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008;295:H931–H938.
   PubMed Web of Science ®Google Scholar
• Jayachandran M, Litwiller RD, Owen WG, Miller VM. Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 2009;12:177–184.
   PubMed Web of Science ®Google Scholar
• Mayr M, Niederseer D, Niebauer J. From bench to bedside: what physicians need to know about endothelial progenitor cells. Am J Med 2011;124:489–497.
   PubMed Web of Science ®Google Scholar
• Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, Giacca M. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006;107:3546–3554.
   PubMed Web of Science ®Google Scholar
• Fadini GP, de Kreutzenberg S, Albiero M, Coracina A, Pagnin E, Baesso I, Cignarella A, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008;28:997–1004.
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999–1007.
   PubMed Web of Science ®Google Scholar
• Lemieux C, Cloutier I, Tanguay JF. Menstrual cycle influences endothelial progenitor cell regulation: a link to gender differences in vascular protection? Int J Cardiol 2009;136:200–210.
   PubMed Web of Science ®Google Scholar
• Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107:3059–3065.
   PubMed Web of Science ®Google Scholar
• Hoetzer GL, MacEneaney OJ, Irmiger HM, Keith R, Van Guilder GP, Stauffer BL, DeSouza CA. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007;99:46–48.
   PubMed Web of Science ®Google Scholar
• Maas AH, van der Schouw YT, Regitz-Zagrosek V, Swahn E, Appelman YE, Pasterkamp G, Ten Cate H, et al. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J 2011;32:1362–1368.
   PubMed Web of Science ®Google Scholar